1 |
polycystic ovary syndrome
(13122 times)
|
Endocrinology (3203 times)
|
BMI (1528 times) IR (718 times) LH (689 times)
|
1978 Pituitary response to bolus and continuous intravenous infusion of luteinizing hormone-releasing factor in normal women and women with polycystic ovarian syndrome.
|
2 |
PCOS group
(18 times)
|
Obstetrics (6 times)
|
FSH (4 times) LH (4 times) BMI (3 times)
|
1997 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
|
3 |
polycystic ovarian disease
(10 times)
|
Reproductive Medicine (4 times)
|
AMPK (1 time) AN (1 time) aOR (1 time)
|
1987 Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.
|
4 |
Prostate Cancer Care and Outcomes Study
(5 times)
|
Medicine (3 times)
|
ADT (1 time) CAMs (1 time) HRQoL (1 time)
|
2011 Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.
|
5 |
Prostate Cancer Outcomes Study
(5 times)
|
Urology (3 times)
|
CI (3 times) CEASAR (1 time) OR (1 time)
|
2000 Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study.
|
6 |
PCO syndrome
(3 times)
|
Endocrinology (2 times)
|
PCO (2 times) AD (1 time) EGF (1 time)
|
1990 Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles.
|
7 |
PCOS-d
(2 times)
|
Endocrinology (2 times)
|
AMH (1 time) NW-g (1 time)
|
2016 Evidence for Increased 5alpha-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.
|
8 |
polycystic ovarian disease syndrome
(2 times)
|
Genetics (1 time)
|
AA (1 time) COX (1 time) GDF15 (1 time)
|
2013 Gene bionetworks that regulate ovarian primordial follicle assembly.
|
9 |
groups: control;polycystic ovary syndrome
(1 time)
|
Biochemistry (1 time)
|
ADM (1 time) ATF6 (1 time) Bcl-2 (1 time)
|
2021 Potential effect of adrenomedullin on metabolic and endocrinal dysfunctions in the experimentally induced polycystic ovary: Targeting implication of endoplasmic reticulum stress.
|
10 |
IV-polycystic ovariorum syndrome
(1 time)
|
Gynecology (1 time)
|
ACA (1 time) aPL (1 time) APTT (1 time)
|
2000 [Antiphospholipid autoantibodies in women treated for infertility].
|
11 |
non-PCOS groups did not differ significantly
(1 time)
|
|
HOMA-IR (1 time) LGI (1 time)
|
2019 Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
|
12 |
palliative care order set
(1 time)
|
Health Services (1 time)
|
CMO (1 time)
|
2011 Impact of standardized palliative care order set on end-of-life care in a community teaching hospital.
|
13 |
parameters were comparable between Fathers
(1 time)
|
Endocrinology (1 time)
|
BMI (1 time) FGI (1 time) FI (1 time)
|
2003 Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
|
14 |
Patient-Centered Outcomes Spectrum
(1 time)
|
General Surgery (1 time)
|
EGS (1 time)
|
2017 Patient-Centered Outcome Spectrum: An Evidence-based Framework to Aid in Shared Decision-making.
|
15 |
patients about their condition
(1 time)
|
Public Health (1 time)
|
---
|
2008 Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome.
|
16 |
patients with micropolycystic ovary syndrome
(1 time)
|
Endocrinology (1 time)
|
---
|
1988 Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome.
|
17 |
PCO rats
(1 time)
|
Endocrinology (1 time)
|
PCO-SON rats (1 time) SON (1 time)
|
2018 Sympathetic innervation regulates macrophage activity in rats with polycystic ovary.
|
18 |
PCO Scale
(1 time)
|
Education (1 time)
|
J-PCOS (1 time) PCO (1 time)
|
2021 Translating and validating a Japanese version of the Patient Care Ownership Scale: a multicenter cross-sectional study.
|
19 |
PCOS compared to controls
(1 time)
|
Endocrinology (1 time)
|
FMD (1 time) IMT (1 time) NID (1 time)
|
2006 Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
|
20 |
PCOS group, PCOSG
(1 time)
|
Gynecology (1 time)
|
QoL (1 time) RET (1 time)
|
2016 Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training.
|
21 |
PCOS only
(1 time)
|
Internal Medicine (1 time)
|
FMD (1 time)
|
2017 Association between polycystic ovary syndrome and the risk of subclinical vascular disease in normal‑weight women with type 1 diabetes.
|
22 |
PCOS patients during the proliferative phase
(1 time)
|
Molecular Biology (1 time)
|
EMT (1 time) MAPK (1 time) nPCOS (1 time)
|
2020 Alterations of endometrial epithelial-mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro.
|
23 |
PCOS receiving no treatment
(1 time)
|
Endocrinology (1 time)
|
IL (1 time) SISAF (1 time) TNF (1 time)
|
2019 Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state.
|
24 |
PCOS women
(1 time)
|
Endocrinology (1 time)
|
FMD (1 time) IMT (1 time) NID (1 time)
|
2006 Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
|
25 |
PCOS-Anov
(1 time)
|
Endocrinology (1 time)
|
AGEs (1 time) AMH (1 time) Non-PCOS Anov (1 time)
|
2009 Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
|
26 |
PCOS-EVs
(1 time)
|
Endocrinology (1 time)
|
CAT (1 time) EVs (1 time) GSS (1 time)
|
2022 Inhibition of oocyte maturation by follicular extracellular vesicles of non-hyperandrogenic PCOS patients requiring IVF.
|
27 |
PCOS-noPM
(1 time)
|
Endocrinology (1 time)
|
CI (1 time) OR (1 time) PM (1 time)
|
2021 The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
|
28 |
PCOS-SNPs
(1 time)
|
Reproductive Medicine (1 time)
|
C9orf3 (1 time) DENND1A (1 time) GWAS (1 time)
|
2015 Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
|
29 |
PCOSEs
(1 time)
|
Reproductive Medicine (1 time)
|
SHBG (1 time)
|
2006 Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.
|
30 |
pellets containing DHT
(1 time)
|
Endocrinology (1 time)
|
DHT (1 time) EA (1 time) GLUT4 (1 time)
|
2010 Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
|
31 |
physiopathological condition
(1 time)
|
Medicine (1 time)
|
IR (1 time) LEP (1 time)
|
2004 [Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance].
|
32 |
PLGA-coated-only stents
(1 time)
|
Cardiology (1 time)
|
BMS (1 time) PCSES (1 time) PLGA (1 time)
|
2009 Long-term effects of novel biodegradable, polymer-coated, sirolimus-eluting stents on neointimal formation in a porcine coronary model.
|
33 |
policistico
(1 time)
|
Gynecology (1 time)
|
ALA (1 time)
|
2020 [Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].
|
34 |
polycystic
(1 time)
|
Physiology (1 time)
|
BMI (1 time) NC (1 time) PC (1 time)
|
2022 Effect of sodium alginate supplementation on weight management and reproductive hormones in polycystic females.
|
35 |
Polycystic ovarian, or stein leventhal, syndrome
(1 time)
|
Fertility (1 time)
|
AFM (1 time) CZ (1 time) IL-18 (1 time)
|
2023 Silver Nanoparticles Biofabricated from Cinnamomum zeylanicum Reduce IL-6, IL-18, and TNF-ɑ in Female Rats with Polycystic Ovarian Syndrome.
|
36 |
Polycystic Ovary Syndrome women
(1 time)
|
Biochemistry (1 time)
|
OAT (1 time) OATP (1 time) WB (1 time)
|
2015 Expression of steroid sulfated transporters and 3beta-HSD activity in endometrium of women having polycystic ovary syndrome.
|
37 |
Polycystic syndrome
(1 time)
|
Gynecology (1 time)
|
---
|
2012 Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
|
38 |
population/s was mostly represented by hyperhomocysteinemia in both the cohorts
(1 time)
|
Reproductive Medicine (1 time)
|
---
|
2022 Significance of Hyperhomocysteinemia in Immediate As Well As Long-Term Health Risk/s in Women with Polycystic Ovary Syndrome: a Probabilistic Model Using Dynamic Bayesian Network Analysis.
|
39 |
posterior circulation stroke
(1 time)
|
Brain (1 time)
|
TVSs (1 time)
|
2021 Transient Vestibular Symptoms Preceding Posterior Circulation Stroke: A Prospective Multicenter Study.
|
40 |
potential (CCL2, IL-6, ORM1, TNAIFP6, SFRP4, SPARC). eSF
(1 time)
|
Endocrinology (1 time)
|
eEPs (1 time) eSFs (1 time)
|
2013 Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
|
41 |
pregnancy hypertension
(1 time)
|
Reproductive Medicine (1 time)
|
aRRs (1 time) ART (1 time) CIs (1 time)
|
2022 Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis.
|
42 |
prooncogenic changes, independent of body mass index, especially in eEP
(1 time)
|
Endocrinology (1 time)
|
eEPs (1 time) eSFs (1 time)
|
2013 Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
|
43 |
Prospective study of age-matched, nonpolycystic ovary syndrome
(1 time)
|
Infertility (1 time)
|
DHEAS (1 time) FF (1 time) IVF (1 time)
|
2016 Follicular fluid dehydroepiandrosterone sulfate is a credible marker of oocyte maturity and pregnancy outcome in conventional in vitro fertilization cycles.
|
44 |
purified COS products
(1 time)
|
Carbohydrates (1 time)
|
COS (1 time) DP (1 time) HLP (1 time)
|
2017 Enzymatic single-step preparation and antioxidant activity of hetero-chitooligosaccharides using non-pretreated housefly larvae powder.
|
45 |
pyrolyzed crushed oyster shells
(1 time)
|
Environmental Health (1 time)
|
ORP (1 time)
|
2022 Field study on short-term changes in benthic environment and benthic microbial communities using pyrolyzed oyster shells.
|
46 |
registries-Prostate Cancer Outcomes Study
(1 time)
|
Neoplasms (1 time)
|
CaPSURE (1 time) CPDR (1 time) PSA (1 time)
|
2004 Prostate cancer 2004: insights from national disease registries.
|